| scholarly article | Q13442814 |
| P356 | DOI | 10.1086/595569 |
| P8608 | Fatcat ID | release_ywvxf34oyvhotjpixeywrjmsky |
| P698 | PubMed publication ID | 19086815 |
| P5875 | ResearchGate publication ID | 23667808 |
| P50 | author | Patrick S. Sullivan | Q39915183 |
| P2093 | author name string | Khalil G Ghanem | |
| Emily J Erbelding | |||
| Lee Warner | |||
| Maurizio Macaluso | |||
| Daniel R Newman | |||
| P2860 | cites work | Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 |
| Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women | Q22337442 | ||
| Creating a conversation: insights from the development of a decision aid | Q28219217 | ||
| Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
| Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 | ||
| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial | Q29619176 | ||
| Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial | Q29619179 | ||
| Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States | Q30233059 | ||
| Declining rates in male circumcision amidst increasing evidence of its public health benefit | Q30834251 | ||
| Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. | Q33926032 | ||
| Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture | Q34147892 | ||
| Heterosexual transmission of HIV in Haiti | Q34386541 | ||
| Potential HIV-1 target cells in the human penis | Q34548480 | ||
| Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities | Q34718905 | ||
| Condom effectiveness for prevention of Chlamydia trachomatis infection | Q35531826 | ||
| Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness | Q37865164 | ||
| Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status | Q37867834 | ||
| Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda | Q38885289 | ||
| Fleeting foreskins: the misclassification of male circumcision status | Q40702843 | ||
| Circumcision and male-to-male sexual transmission of HIV. | Q45252831 | ||
| The association between circumcision status and human immunodeficiency virus infection among homosexual men. | Q45777557 | ||
| Using validation sets for outcomes and exposure to infection in vaccine field studies. | Q52934276 | ||
| Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. | Q53624910 | ||
| HIV and male circumcision?a systematic review with assessment of the quality of studies | Q56531033 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sexually transmitted infection | Q12198 |
| P304 | page(s) | 59-65 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. | |
| P478 | volume | 199 |
| Q92731968 | "Getting to Zero New HIV Infections in the Caribbean": Knowledge and Attitudes Toward Male Circumcision Among Adolescent Males in The Bahamas |
| Q34277425 | A census tract-level examination of social determinants of health among black/African American men with diagnosed HIV infection, 2005-2009--17 US areas |
| Q56563812 | A review of the Centers for Disease Control and Prevention's response to the HIV/AIDS crisis among Blacks in the United States, 1981-2009 |
| Q37472898 | An African perspective on mucosal immunity and HIV-1. |
| Q35870576 | Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials |
| Q45347688 | Attitudes, Beliefs and Predictors of Male Circumcision Promotion among Medical University Students in a Traditionally Non-Circumcising Region |
| Q22252602 | Behavioral aspects of male circumcision for the prevention of HIV infection |
| Q33817766 | CDC's Male Circumcision Recommendations Represent a Key Public Health Measure |
| Q49579785 | Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version). |
| Q57871047 | Considerations in the role of male circumcision in the prevention of HIV transmission in the USA |
| Q21562586 | Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males |
| Q24630822 | Costs and effectiveness of neonatal male circumcision |
| Q38171861 | Counseling parents who are considering newborn male circumcision |
| Q93181636 | Critical evaluation of arguments opposing male circumcision: A systematic review |
| Q36442232 | Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis |
| Q33692776 | Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny |
| Q37630319 | Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy |
| Q51849137 | High HIV prevalence and diagnosis rates in New York City black men. |
| Q30404393 | Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review |
| Q35944781 | In developed countries male circumcision prevalence is inversely related to HIV prevalence |
| Q35542152 | Interventions to prevent sexually transmitted infections, including HIV infection |
| Q55017183 | La circoncision néonatale. |
| Q28237994 | Male circumcision and HIV infection risk |
| Q34010053 | Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision |
| Q28300040 | Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections |
| Q43182526 | Male circumcision: integrating tradition and medical evidence. |
| Q83668391 | Medicaid coverage of newborn circumcision: a health parity right of the poor |
| Q28268089 | Newborn male circumcision |
| Q34333833 | Out of step: fatal flaws in the latest AAP policy report on neonatal circumcision |
| Q33696533 | Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States |
| Q24621538 | Review: a critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries |
| Q36844804 | Sexually transmitted infections and male circumcision: a systematic review and meta-analysis |
| Q38027019 | The 2010 Royal Australasian College of Physicians' policy statement 'Circumcision of infant males' is not evidence based |
| Q36355708 | The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding |
| Q34221409 | The medical benefits of male circumcision |
| Q44045974 | Veracity and rhetoric in paediatric medicine: a critique of Svoboda and Van Howe's response to the AAP policy on infant male circumcision |
Search more.